Explore more publications!
The Middle East Health Journal
Got News to Share?

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 8, 2026

Solaris Endovascular Announces Completion of Enrollment in DEScover Trial
January 8, 2026

Solaris Endovascular Announces Completion of Enrollment in DEScover Trial

Indeterminate EIN Presswire
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
January 8, 2026

Ryoncil® Sales Increase 60% in December Quarter to US$35.1M

Indeterminate GlobeNewswire
AI Is Changing the Rules of Sales and Marketing
January 8, 2026

AI Is Changing the Rules of Sales and Marketing

Indeterminate EIN Presswire
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
January 8, 2026

Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

Indeterminate GlobeNewswire
Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 - by Crazy Nutrition
January 8, 2026

Best Creatine Supplements for Women And Men 2026: Effective Creatine For Muscle Growth & Weight loss For Women Over 40, 50 - by Crazy Nutrition

Indeterminate GlobeNewswire
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
January 8, 2026

SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer

Indeterminate GlobeNewswire
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
January 8, 2026

Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments

Indeterminate GlobeNewswire
AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals
January 8, 2026

AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals

Indeterminate GlobeNewswire
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
January 8, 2026

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

Indeterminate GlobeNewswire
Cellectis Announces 2026 Strategy and Catalysts
January 8, 2026

Cellectis Announces 2026 Strategy and Catalysts

Indeterminate GlobeNewswire
Cellectis annonce sa stratégie et ses jalons attendus en 2026
January 8, 2026

Cellectis annonce sa stratégie et ses jalons attendus en 2026

Indeterminate GlobeNewswire
World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months
January 8, 2026

World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months

Indeterminate GlobeNewswire
AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals
January 8, 2026

AAFA Affirms Public Health Value of Vaccines as Nearly Everyone Is High Risk or Lives in Community with High Risk Individuals

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Grants of Inducement Awards
January 8, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
January 8, 2026

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Indeterminate GlobeNewswire
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
January 8, 2026

Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer

Indeterminate GlobeNewswire
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
January 8, 2026

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

Indeterminate GlobeNewswire
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
January 8, 2026

Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance

Indeterminate GlobeNewswire
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
January 8, 2026

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

Indeterminate GlobeNewswire
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
January 8, 2026

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions